Search results
Roche’s oral GLP-1 receptor agonist shows promising early weight loss results in phase 1
BioPharma-Reporter· 3 days agoRoche acquired CT-996 as part of its $2.7 billion acquisition of Carmot Therapeutics, a biotech...
Long Covid and Vaccination: What You Need to Know
New York Times· 4 days agoA new study adds to evidence that the shots can reduce the chances of developing one of the most dreaded consequences of Covid. A summer wave of Covid is...
Roche touts early trial success of second obesity drug candidate
Reuters via Yahoo Finance Canada· 4 days ago(Reuters) -Roche said on Wednesday a second drug candidate from its purchase of Carmot Therapeutics...